A microarray analysis of urinary microRNAs in renal diseases

Clinical and Experimental Nephrology

Volumn 18, Issue 5, 2014, Pages 711-717

  Konta, Tsuneo ^a   Ichikawa, Kazunobu ^a   Suzuki, Kazuko ^a   Kudo, Kosuke ^a   Satoh, Hiroko ^a   Kamei, Keita ^a   Nishidate, Emiko ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; MicroRNA; Urine

Indexed keywords

BETA 2 MICROGLOBULIN; MICRORNA; MICRORNA 1246; MICRORNA 1260; MICRORNA 1260B; MICRORNA 1274A; MICRORNA 1274B; MICRORNA 141; MICRORNA 193B; MICRORNA 194; MICRORNA 197; MICRORNA 21; MICRORNA 22; MICRORNA 30A; MICRORNA 30C; MICRORNA 30D; MICRORNA 30E; MICRORNA 3137; MICRORNA 3156; MICRORNA 342 3P; MICRORNA 4253; MICRORNA 4290; MICRORNA 483 5P; MICRORNA 494; MICRORNA 583; MICRORNA 595; MICRORNA 601; MICRORNA 631; MICRORNA 92A; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROL; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROTEIN URINE LEVEL; RNA DEGRADATION; RNA EXTRACTION; URINALYSIS; URINE SEDIMENT; AGED; CASE CONTROL STUDY; DIABETIC NEUROPATHY; DNA MICROARRAY; GENE EXPRESSION PROFILING; LIPOID NEPHROSIS; MIDDLE AGED; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIABETIC NEUROPATHIES; FEMALE; GENE EXPRESSION PROFILING; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEPHROSIS, LIPOID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84919343013     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0906-5     Document Type: Article

References (36)

1. Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009;4:1255–66.
2. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74.
3. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol. 2008;19:2069–75.
4. Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol. 2008;19:2159–69.
5. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, et al. Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab Invest. 2010;90:98–103.
6. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol. 2010;21:438–47.
7. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, et al. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens. 2010;23:78–84.
8. Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton). 2012;17:346–51.
9. Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One. 2013;8:e58014.
10. Wang G, Kwan BC, Lai FM, Chow KM, Kam-Tao Li P, et al. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis Markers. 2010;28:79–86.
11. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers. 2011;30:171–9.
12. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC. Urinary sediment miRNA levels in adult nephrotic syndrome. Clin Chim Acta. 2013;418:5–11.
13. Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S, et al. Increased serum and urinary MicroRNAs in children with idiopathic nephrotic syndrome. Clin Chem. 2013;59:658–66.
14. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus. 2011;20:493–500.
15. Lorenzen JM, Thum T. Circulating and urinary microRNAs in kidney disease. Clin J Am Soc Nephrol. 2012;7:1528–33.
16. Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011;11:2110–22.
17. Ichii O, Otsuka S, Sasaki N, Namiki Y, Hashimoto Y, Kon Y. Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int. 2012;81:280–92.
18. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733–41.
19. Argyropoulos C, Wang K, McClarty S, Huang D, Bernardo J, Ellis D, et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One. 2013;8:e54662.
20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
21. Takahashi T, Konta T, Takasaki S, Ichikawa K, Takeishi Y, Kubota I. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy. Clin Exp Nephrol. 2007;11:202–8.
22. Miura K, Miura S, Yamasaki K, Higashijima A, Kinoshita A, Yoshiura K, et al. Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem. 2010;56:1767–71.
23. Li JY, Yong TY, Michael MZ, Gleadle JM. The role of microRNAs in kidney disease. Nephrology (Carlton). 2010;15:599–608.
24. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004;101:13368–73.
25. Miranda KC, Bond DT, McKee M, Skog J, Păunescu TG, Da Silva N, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010;78:191–9.
26. Denby L, Ramdas V, McBride MW, Wang J, Robinson H, McClure J, et al. miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol. 2011;179:661–72.
27. Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia. 2013;56:663–74.
28. Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA. 2010;107:14339–44.
29. Xu X, Kriegel AJ, Liu Y, Usa K, Mladinov D, Liu H, et al. Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int. 2012;82:1167–75.
30. Wang N, Zhou Y, Jiang L, Li D, Yang J, Zhang CY, et al. Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injury. PLoS One. 2012;7:e51140.
31. Macconi D, Tomasoni S, Romagnani P, Trionfini P, Sangalli F, Mazzinghi B, et al. MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J Am Soc Nephrol. 2012;23:1496–505.
32. Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, et al. Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines. Int J Oncol. 2012;40:951–9.
33. Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J, et al. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int Immunopharmacol. 2012;13:468–75.
34. Guérit D, Philipot D, Chuchana P, Toupet K, Brondello JM, Mathieu M, et al. Sox9-regulated miRNA-574-3p inhibits chondrogenic differentiation of mesenchymal stem cells. PLoS One. 2013;8:e62582.
35. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010;78:838–48.
36. Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82:1024–32.